MedTrace Logo

Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.

NCT05317312 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2023-08-07

Study results available
· View outcomes & findings →

Summary

MR-107A-02 is being studied to investigate its efficacy, safety and dose-response after dental surgery.

Conditions

  • Acute Pain
  • Post Operative Pain
  • Pain

Interventions

DRUG

MR-107A-02

MR-107A-02 oral tablet

DRUG

Placebo

Placebo oral tablet

Sponsors & Collaborators

  • Mylan Specialty, LP

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2022-06-15
Completion
2022-06-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05317312 on ClinicalTrials.gov